[Risk assessment of perioperative adverse events and management of antiplatelet therapy in patients with bladder cancer and coronary atherosclerotic heart disease undergoing transurethral resection of bladder cancer]. [PDF]
Miao Q +8 more
europepmc +1 more source
[Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft]. [PDF]
Chen S +6 more
europepmc +1 more source
[Analysis of urine biomarkers in urothelial carcinoma based on untargeted metabolomics]. [PDF]
Liu S, Wang M, Wang W.
europepmc +1 more source
目的: 探讨无创早期诊断膀胱癌的有效方法: 对膀胱癌患者进行尿液中膀胱肿瘤抗原( BTA)测定与分析。方法: 对 64 例膀胱癌及 28 例非膀胱癌患者的尿进行 BTA 测定及尿脱落细胞学检查, 比较这两种方法的敏感度、特异度、准确度、阳 性及阴性似然比。结果: BTA 测定的敏感度、准确度、特异度、阳性及阴性似然比分别为 90. 6%、89. 3%、90. 2%、8. 5 及 0. 1; 尿脱落细胞学检查这些指标分别为 46. 9%、92. 9%、60. 9%、6. 6 及 0.
doaj
[Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy]. [PDF]
Li S +9 more
europepmc +1 more source
[Pirfenidone inhibits bladder cancer xenograft growth in mice by regulating regulatory T cells]. [PDF]
Zhang H +5 more
europepmc +1 more source
[Apelin promotes proliferation, migration, and angiogenesis in bladder cancer by activating the FGF2/FGFR1 pathway]. [PDF]
Su W +6 more
europepmc +1 more source
Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis. [PDF]
Yin G +5 more
europepmc +1 more source
O-GlcNAcylated YTHDF2 promotes bladder cancer progression by regulating the tumor suppressor gene <i>PER1</i> via m<sup>6</sup>A modification. [PDF]
Wang L +5 more
europepmc +1 more source
[Research progress in the role of STMN1 in tumor]. [PDF]
Ma X, Li M, Chen, Mei H, Rong Z.
europepmc +1 more source

